Literature DB >> 6819104

Application of stable labelled drugs in clinical pharmacokinetic investigations.

M Eichelbaum, G E von Unruh, A Somogyi.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 6819104     DOI: 10.2165/00003088-198207060-00002

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  42 in total

1.  Absolute bioavailability in man of N-acetylprocainamide determined by a novel stable isotope method.

Authors:  J M Strong; J S Dutcher; W K Lee; A J Atkinson
Journal:  Clin Pharmacol Ther       Date:  1975-11       Impact factor: 6.875

2.  Procainamide and N-acetylprocainamide kinetics investigated simultaneously with stable isotope methodology.

Authors:  J S Dutcher; J M Strong; S V Lucas; W K Lee; A J Atkinson
Journal:  Clin Pharmacol Ther       Date:  1977-10       Impact factor: 6.875

3.  Comparison of observed and predicted first-pass metabolism of imipramine in humans.

Authors:  S Niazi
Journal:  J Pharm Sci       Date:  1976-07       Impact factor: 3.534

Review 4.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

Review 5.  The use of stable isotopes in medicinal chemistry.

Authors:  D Halliday; I M Lockhart
Journal:  Prog Med Chem       Date:  1978

6.  Kinetics of R andS warfarin enantiomers.

Authors:  C Hignite; J Uetrecht; C Tschanz; D Azarnoff
Journal:  Clin Pharmacol Ther       Date:  1980-07       Impact factor: 6.875

7.  Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses.

Authors:  M Eichelbaum; K Ekbom; L Bertilsson; V A Ringberger; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1975-06-13       Impact factor: 2.953

8.  Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy.

Authors:  M Eichelbaum; L Bertilsson; L Lund; L Palmér; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

9.  [Teratogenicity of anticonvulsant drugs (author's transl)].

Authors:  F Majewski; W Raff; P Fischer; R Huenges; F Petruch
Journal:  Dtsch Med Wochenschr       Date:  1980-05-16       Impact factor: 0.628

10.  Capillary column GLC-mass spectrometric assay with selected-ion monitoring for timolol and [13C3]timolol in human plasma.

Authors:  J R Carlin; R W Walker; R O Davies; R T Ferguson; W J Vandenheuvel
Journal:  J Pharm Sci       Date:  1980-10       Impact factor: 3.534

View more
  6 in total

1.  Application of stable isotope methodology to study the pharmacokinetics, bioavailability and metabolism of nitrendipine after i.v. and p.o. administration.

Authors:  G Mikus; C Fischer; B Heuer; C Langen; M Eichelbaum
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

2.  Concurrent intravenous administration of a labeled tracer to determine the oral bioavailability of a drug exhibiting Michaelis-Menten metabolism.

Authors:  G M Rubin; J A Waschek; S M Pond; D J Effeney; T N Tozer
Journal:  J Pharmacokinet Biopharm       Date:  1987-12

3.  Use of stable isotopes for evaluation of drug delivery systems: comparison of ibuprofen release in vivo and in vitro from two biphasic release formulations utilizing different rate-controlling polymers.

Authors:  D L Theis; L J Lucisano; G W Halstead
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

4.  A method for determination of the absolute pulmonary bioavailability of inhaled drugs: terbutaline.

Authors:  L Borgström; M Nilsson
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

5.  Pharmacokinetics of lignocaine and bupivacaine in surgical patients following epidural administration. Simultaneous investigation of absorption and disposition kinetics using stable isotopes.

Authors:  A G Burm; N P Vermeulen; J W van Kleef; A G de Boer; J Spierdijk; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

6.  An investigation of the cause of accumulation of verapamil during regular dosing in patients.

Authors:  J B Schwartz; D R Abernethy; A A Taylor; J R Mitchell
Journal:  Br J Clin Pharmacol       Date:  1985-04       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.